Want to see AU:EVE full AI Analyst Report?
EVE Health Group Limited (EVE) Price & Analysis
EVE Stock Chart & Stats
- Day’s Range
- AUD 0.01 - AUD 0.01
- 52-Week Range
- AUD 0.01 - AUD 0.03
- Previous Close
- AUD 0.01
- Volume
- 9,814
- Average Volume (3M)
- 558.35K
- Market Cap
- AUD 4.76M
- Enterprise Value
- AUD 4.86M
- Total Cash (Recent Filing)
- AUD 1.24M
- Total Debt (Recent Filing)
- AUD 0
- Price to Earnings (P/E)
- ―
- Beta
- 0.21
- Next Earnings
- Mar 01, 2027
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage
A debt-light balance sheet reduces refinancing and interest-rate exposure, preserving financial flexibility while the company restructures. Positive equity also provides a buffer against operating volatility and gives management more capacity to allocate resources without heavy creditor constraints.
Losses Narrowing
The reduction in losses indicates some improvement from the company’s earlier financial trough, even though profitability remains unsustainable. If maintained, this progress could lower the funding required to support operations and create a foundation for eventual operating break-even.
Branded Women’s Health Focus
A focused branded product portfolio gives EVE a defined position within consumer health and women’s wellness rather than relying on an undifferentiated offering. Brand development and category focus can support repeat purchasing and clearer market positioning over time.
Bears Say
Persistent Unprofitability
Persistent losses show that sales are not currently sufficient to cover the company’s cost base, while negative gross profit in the latest period signals particularly severe underlying pressure. This weakens earnings quality and makes sustained self-funded growth difficult.
Declining Revenue
Multi-year revenue contraction indicates that EVE is shrinking rather than scaling, reducing operating leverage and making a path to profitability more difficult. Continued sales declines can also limit investment in product development, marketing, and distribution needed to rebuild demand.
Ongoing Cash Burn
Consistently negative operating and free cash flow means the business is consuming cash instead of funding itself internally. Even with minimal debt, continued burn can draw down balance-sheet resources or increase reliance on external funding, constraining strategic flexibility.
EVE Health Group Limited News
EVE Health Sets November 2026 AGM as It Advances Vertically Integrated Pharma Platform
An announcement from EVE Health Group Limited ( ($AU:EVE) ) is now available. EVE Health Group Limited, an Australian life sciences company, develops and commercialises pharmaceutical products targeting high-growth therapeutic
EVE FAQ
What was EVE Health Group Limited’s price range in the past 12 months?
What is EVE Health Group Limited’s market cap?
When is EVE Health Group Limited’s upcoming earnings report date?
How were EVE Health Group Limited’s earnings last quarter?
Is EVE Health Group Limited overvalued?
Does EVE Health Group Limited pay dividends?
What is EVE Health Group Limited’s EPS estimate?
How many shares outstanding does EVE Health Group Limited have?
What happened to EVE Health Group Limited’s price movement after its last earnings report?
Which hedge fund is a major shareholder of EVE Health Group Limited?
What is the TipRanks Smart Score and how is it calculated?
EVE Health Group Limited Stock Smart Score
Company Description
EVE Health Group Limited
Based in Subiaco, Australia, Eve Health Group Limited, originally incorporated in 2003 as EVE Investments Limited, is an international provider of health, wellness, and nutritional products. The company operates across Australia, New Zealand, the Asia Pacific region, and North America. Its activities include the production of organic tea tree oils, the distribution of botanical oils, and the supply of a wide array of other oils such as essential oils, hydrosols, extracts, carrier oils, and seed oils. Furthermore, Eve Health Group offers organic raw honey and raw honey probiotic concentrates, alongside contract manufacturing services. A key area of its focus is developing medical nutrition solutions for chronic and lifestyle ailments, exemplified by Gluco Smooth, a product designed to help manage type 2 diabetes by moderating post-meal blood sugar levels, as well as providing various dietary intervention programs.
- Sector
- Consumerdefensive
- Industry
- Packaged Foods
- CEO
- Benedict James Rohr
- Employees
- 3
- Website
- www.evehealthgroup.com.au
- Address
- 245 Churchill Avenue, Subiaco, WA, 6008, AU
EVE Health Group Limited (EVE) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 4 | 12 |
| Technical Analysis | 4 | 4 | 1 |
| Moving Averages | 1 | 0 | 11 |





